Genmab A/S (CPH:GMAB)
Denmark
· Delayed Price · Currency is DKK 1,738.00
-37.00 (-2.08%)
Mar 6, 2026, 12:59 PM CET
Genmab Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 3,720 | 3,121 | 2,390 | 2,084 | 1,287 | Upgrade
|
| Revenue Growth (YoY) | 19.19% | 30.59% | 14.68% | 61.88% | -22.52% | Upgrade
|
| Cost of Revenue | 238 | 143 | 33 | - | - | Upgrade
|
| Gross Profit | 3,482 | 2,978 | 2,357 | 2,084 | 1,287 | Upgrade
|
| Selling, General & Admin | 626 | 549 | 478 | 384.48 | 196.24 | Upgrade
|
| Research & Development | 1,606 | 1,414 | 1,107 | 799.14 | 639.51 | Upgrade
|
| Operating Expenses | 2,232 | 1,963 | 1,585 | 1,184 | 835.75 | Upgrade
|
| Operating Income | 1,250 | 1,015 | 772 | 900.43 | 451.68 | Upgrade
|
| Interest Expense | -61 | -18 | -10 | -5.6 | -1.99 | Upgrade
|
| Interest & Investment Income | 138 | 144 | 142 | 46.55 | 30.13 | Upgrade
|
| Currency Exchange Gain (Loss) | -3 | 92 | -66 | 151.01 | 224.85 | Upgrade
|
| EBT Excluding Unusual Items | 1,324 | 1,233 | 838 | 1,092 | 704.67 | Upgrade
|
| Merger & Restructuring Charges | -185 | -43 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 65 | 136 | -21 | -94.54 | -105.39 | Upgrade
|
| Pretax Income | 1,204 | 1,326 | 817 | 997.85 | 599.28 | Upgrade
|
| Income Tax Expense | 241 | 193 | 186 | 214.51 | 146.99 | Upgrade
|
| Net Income | 963 | 1,133 | 631 | 783.33 | 452.29 | Upgrade
|
| Net Income to Common | 963 | 1,133 | 631 | 783.33 | 452.29 | Upgrade
|
| Net Income Growth | -15.00% | 79.56% | -19.45% | 73.19% | -42.16% | Upgrade
|
| Shares Outstanding (Basic) | 62 | 64 | 65 | 65 | 65 | Upgrade
|
| Shares Outstanding (Diluted) | 63 | 65 | 66 | 66 | 66 | Upgrade
|
| Shares Change (YoY) | -3.04% | -1.88% | -0.17% | -0.06% | 0.24% | Upgrade
|
| EPS (Basic) | 15.49 | 17.65 | 9.66 | 11.98 | 6.92 | Upgrade
|
| EPS (Diluted) | 15.37 | 17.53 | 9.58 | 11.87 | 6.85 | Upgrade
|
| EPS Growth | -12.32% | 82.98% | -19.27% | 73.29% | -42.30% | Upgrade
|
| Free Cash Flow | 1,149 | 1,099 | 1,018 | 516.52 | 302.24 | Upgrade
|
| Free Cash Flow Per Share | 18.33 | 17.00 | 15.45 | 7.83 | 4.58 | Upgrade
|
| Gross Margin | 93.60% | 95.42% | 98.62% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | 33.60% | 32.52% | 32.30% | 43.21% | 35.08% | Upgrade
|
| Profit Margin | 25.89% | 36.30% | 26.40% | 37.59% | 35.13% | Upgrade
|
| Free Cash Flow Margin | 30.89% | 35.21% | 42.59% | 24.79% | 23.48% | Upgrade
|
| EBITDA | 1,290 | 1,052 | 802 | 941.81 | 481.35 | Upgrade
|
| EBITDA Margin | 34.68% | 33.71% | 33.56% | 45.19% | 37.39% | Upgrade
|
| D&A For EBITDA | 40 | 37 | 30 | 41.38 | 29.67 | Upgrade
|
| EBIT | 1,250 | 1,015 | 772 | 900.43 | 451.68 | Upgrade
|
| EBIT Margin | 33.60% | 32.52% | 32.30% | 43.21% | 35.08% | Upgrade
|
| Effective Tax Rate | 20.02% | 14.56% | 22.77% | 21.50% | 24.53% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.